DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (112)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 112   Next >>

Possible Prednisone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient: female, weighing 81.8 kg (180.0 pounds)

Reactions: Dyspnoea, Chest Pain, Pancytopenia, Pyrexia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1400 mg

Doxorubicin Hydrochloride
    Dosage: 94 mg

Prednisone
    Dosage: 375 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 700 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Tachycardia, Clostridium Difficile Colitis, Pancytopenia, Neutropenia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2780 mg

Doxorubicin Hydrochloride
    Dosage: 152 mg

Etoposide
    Dosage: 720 mg

Fluorine-18 2-Fluorou-2 Deoxyry-D-Glucose (18f-Fdg)
    Dosage: 12 mg

Prednisone
    Dosage: 1300 mg

Rituximab
    Dosage: 800 mg

Vincristine Sulfate
    Dosage: 3.6 mg



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient: male

Reactions: Central Nervous System Lymphoma, Pyrexia, Thrombocytopenia, Cerebral Toxoplasmosis, Asthenia, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Istodax
    Start date: 2012-03-27

Istodax

Istodax
    Start date: 2012-05-30
    End date: 2012-05-30

Prednisone
    Dosage: 25 milligram
    Administration route: Oral

Prednisone
    Dosage: 50 milligram

Other drugs received by patient: Levothyroxine Sodium; Prednisone TAB; Omeprazole; Kytril



Possible Prednisone side effects in 41 year old female

Reported by a physician from United States on 2012-08-07

Patient: 41 year old female

Reactions: Night Sweats, Chills, Intestinal Mass, Pyrexia, Hypoaesthesia, Appendicitis, Postoperative Wound Infection, Alopecia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humira
    Start date: 2012-07-06
    End date: 2012-07-06

Humira
    Indication: Crohn's Disease
    Start date: 2012-06-08
    End date: 2012-06-08

Humira
    Start date: 2012-06-22
    End date: 2012-06-22

Humira
    Indication: Crohn's Disease
    Start date: 2012-07-06

Prednisone
    Indication: Crohn's Disease
    End date: 2012-06-01

Other drugs received by patient: Hydrocodone Bitartrate; Tylenol



Possible Prednisone side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 46 year old female

Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carmustine

Cyclophosphamide
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine

Cytarabine
    Dosage: 1.5 g/d/m2 (1 cycle)

Doxorubicin Hydrochloride
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide

Idarubicin HCL
    Dosage: 12 mg/d/m2 (1 cycle)

Melphalan Hydrochloride

Oncovin
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 8 courses
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab

Vorinostat
    Dosage: 1 cycle
    Administration route: Oral



Possible Prednisone side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 46 year old female

Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Carmustine
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Myelodysplastic Syndrome

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Suberoylanilide Hydroxamic Acid
    Dosage: 500 mg, tid
    Administration route: Oral
    Indication: Myelodysplastic Syndrome

Other drugs received by patient: Radiotherapy



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 54.1 kg (119.0 pounds)

Reactions: Pneumonia Primary Atypical, Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Certican
    Dosage: 1.5 mg, bid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-09-09

Certican
    Dosage: 0.75 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-28
    End date: 2011-02-02

Certican
    Dosage: 0.75 mg, bid
    Administration route: Oral
    Start date: 2011-09-10

Leflunomide

Mycophenolate Mofetil
    Dosage: 250 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-01-24
    End date: 2012-01-29

Prednisone
    Indication: Immunosuppression

Prednisone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-28

Prograf
    Dosage: 01 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-28

Prograf
    Indication: Immunosuppression

Valcyte
    Dosage: 450 mg, bid
    Administration route: Oral
    Indication: Cytomegalovirus Viraemia
    Start date: 2011-08-25

Other drugs received by patient: Lasix



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 50.6 kg (111.3 pounds)

Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-16

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-24

Patient: female, weighing 51.4 kg (113.1 pounds)

Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    End date: 2011-05-16

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-04

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-24

Prograf
    Dosage: 4 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09

Prograf
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in 66 year old female

Reported by a physician from United States on 2012-07-23

Patient: 66 year old female, weighing 65.3 kg (143.7 pounds)

Reactions: Foot Deformity, Back Pain, Pelvic Fracture, Localised Infection, Pneumonia, Laceration, Blood Potassium Increased, Blood Magnesium Decreased, Pyrexia, Cystitis, Fall, Respiratory Tract Congestion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Enbrel
    Dosage: 50 mg, qwk
    Indication: Rheumatoid Arthritis
    Start date: 2002-12-01
    End date: 2012-06-01

Enbrel
    Dosage: 50 mg, qwk
    Indication: Osteoporosis
    Start date: 2000-05-22

Prednisone
    Dosage: unk



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Weight Decreased, Drug Dose Omission, Vomiting, Crohn's Disease, Chills, Decreased Activity, Pain, Pyrexia, Hyperhidrosis, Loss of Consciousness, Malaise, Hyperphagia, Diarrhoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Indication: Crohn's Disease
    Start date: 2012-01-01

Remicade
    Indication: Crohn's Disease
    Start date: 2010-01-01
    End date: 2011-11-01

Remicade
    Start date: 2012-01-01
    End date: 2012-04-01



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-18

Patient: female, weighing 59.1 kg (130.0 pounds)

Reactions: Abdominal Pain, Dehydration, Pancytopenia, Pyrexia, Neutropenia, Asthenia, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1250 mg

Doxorubicin Hydrochloride
    Dosage: 84 mg

Prednisone
    Dosage: 200 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 620 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: male, weighing 98.9 kg (217.6 pounds)

Reactions: Liver Function Test Abnormal, Pyrexia, Leukocytosis, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-14
    End date: 2011-10-15

Thymoglobulin
    Dosage: unk
    Indication: Transplant Rejection
    Start date: 2011-10-04
    End date: 2011-10-12

Other drugs received by patient: Valcyte; Albuterol; Bactrim; Pepcid; Tacrolimus; Vitamin D; Doxazosin Mesylate; Amlodipine; Metoprolol Succinate; Cellcept; Cefepime; Docusate; Nystatin; Famotidine; Fluticasone Propionate



Possible Prednisone side effects in male

Reported by a physician from Netherlands on 2012-06-25

Patient: male

Reactions: Urinary Tract Infection, Dysuria, Pollakiuria, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Certican
    Dosage: unk
    Indication: Renal Transplant
    Start date: 2008-02-22

Neoral
    Dosage: unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2008-02-22

Prednisone



Possible Prednisone side effects in female

Reported by a physician from Japan on 2012-06-19

Patient: female

Reactions: Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acarbose
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Actemra
    Start date: 2010-05-06

Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2009-02-10
    End date: 2010-03-09

Aspirin
    Administration route: Oral
    Indication: Prophylaxis

Azosemide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Celecoxib
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Clopidogrel Bisulfate
    Administration route: Oral
    Indication: Prophylaxis

Glimepiride
    Administration route: Oral
    Indication: Diabetes Mellitus

Prednisolone
    Administration route: Oral
    Start date: 2009-04-07

Prednisone
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2009-01-01
    End date: 2009-04-06

Rabeprazole Sodium
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Rebamipide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Thyroid TAB
    Administration route: Oral
    Indication: Hypothyroidism

Other drugs received by patient: Pamilcon; Incremin (Japan); Trichlormethiazide; Norvasc; Naboal



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-19

Patient: female

Reactions: Pyrexia, Wound Secretion, Cartilage Atrophy, Feeling Cold, Tendon Injury, Tendon Pain, Fatigue, Joint Crepitation, Arthropathy, Fracture, Oedema Peripheral, Bacterial Infection, Joint Effusion, Hypersomnia, Musculoskeletal Pain, Osteopenia, Cartilage Injury, Radiation Associated Pain, Osteoarthritis, Osteosclerosis, Chondromalacia, Arthralgia, Joint Swelling, Tendon Disorder, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Ciprofloxacin HCL
    Dosage: unk
    Indication: Post Procedural Infection
    Start date: 2010-09-01

Prednisone
    Dosage: unk
    Indication: Pain
    Start date: 2010-09-01
    End date: 2010-12-29

Prednisone
    Dosage: 10 mg, qd
    Indication: Oedema Peripheral
    Start date: 2011-02-01
    End date: 2011-11-01

Other drugs received by patient: Vancomycin; Zanaflex; Cholecalciferol; Zosyn; Trimethoprim + Sulfamethoxazole



Possible Prednisone side effects in 71 year old male

Reported by a individual with unspecified qualification from United Kingdom on 2012-06-15

Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)

Reactions: Haemoglobin Decreased, Chest Pain, Platelet Count Decreased, Pyrexia, Troponin Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Gemcitabine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Neulasta
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-02

Prednisone
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Rituximab
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Vincristine Sulfate
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Other drugs received by patient: Metoclopramide; Cotrim; Tramadol HCL



Possible Prednisone side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-06-05

Patient: 69 year old male

Reactions: Productive Cough, Dyspnoea, Hypotension, Pyrexia, Interstitial Lung Disease, Septic Shock, White Blood Cell Count Increased, Cough, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Prophylaxis

Prednisone
    Indication: Premedication

Taxotere
    Dosage: over 1 hour
    Indication: Prostate Cancer

Taxotere
    Dosage: over 1 hour

Taxotere
    Dosage: cumulative dosage in 3rd cycle: 350 mg

Other drugs received by patient: Estramustine



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male, weighing 85.9 kg (189.0 pounds)

Reactions: Atelectasis, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg

Doxorubicin Hydrochloride
    Dosage: 80 mg

Etoposide
    Dosage: 400 mg

Prednisone
    Dosage: 1200 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 750 mg

Vincristine Sulfate
    Dosage: 7.2 mg



Possible Prednisone side effects in 59 year old female

Reported by a physician from United States on 2012-05-24

Patient: 59 year old female

Reactions: Pneumonia, Drug Effect Decreased, Chills, Blood Triglycerides Increased, Psoriasis, Pyrexia, Chronic Obstructive Pulmonary Disease, Respiratory Tract Congestion, Basal Cell Carcinoma, Pulmonary Oedema, Sleep Apnoea Syndrome, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humira
    Indication: Psoriasis
    Start date: 2011-05-10
    End date: 2012-04-03

Prednisone
    Indication: Pneumonia
    Start date: 2012-04-01

Other drugs received by patient: Simvastatin; Lisinopril; Depakote; Restoril; Pravastatin; Geodon; Diltiazem; Seroquel; Acyclovir



Possible Prednisone side effects in

Reported by a physician from United States on 2012-05-18

Patient:

Reactions: Pancytopenia, Pyrexia, Haematoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 6 mg/m2, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-19
    End date: 2011-11-09

Prednisone
    Dosage: 80 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-19
    End date: 2011-11-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-04-19
    End date: 2011-11-09

Other drugs received by patient: Iron; Hyperium / 00939801 /; Nicardipine HCL; Vitamin D; Aranesp



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient:

Reactions: Urticaria, Headache, Pyrexia, Oropharyngeal Pain, Constipation, Polyneuropathy, Fatigue, Dyspepsia, Oedema Peripheral, Cough, Dyspnoea, Vomiting, Nausea, Rash, Dysgeusia, Diarrhoea, Alopecia, Neutropenia, Respiratory Tract Infection, Leukopenia, Infection, Infusion Related Reaction

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Ofatumumab
    Indication: B-Cell Lymphoma

Ofatumumab

Prednisone
    Administration route: Oral
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Other drugs received by patient: Cetirizine; Acetaminophen; Glucocorticoids



Possible Prednisone side effects in 27 year old female

Reported by a physician from Switzerland on 2012-05-18

Patient: 27 year old female, weighing 67.0 kg (147.4 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humira
    Indication: Crohn's Disease
    Start date: 2012-03-15
    End date: 2012-03-15

Humira

Humira

Prednisone
    Administration route: Oral

Prednisone
    Administration route: Oral
    Indication: Crohn's Disease
    Start date: 2012-03-15

Other drugs received by patient: Solevita Forte; Belara



Possible Prednisone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-08

Patient: female, weighing 40.5 kg (89.1 pounds)

Reactions: Vomiting, Dyspnoea, Chest Discomfort, Lactobacillus Infection, Nausea, Device Related Infection, Pyrexia, Diarrhoea, Staphylococcal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1028 mg

Doxil
    Dosage: 55 mg

Prednisone
    Dosage: 500 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 514 mg

Vincristine Sulfate
    Dosage: 1.9 mg



Possible Prednisone side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-05-07

Patient: 77 year old female

Reactions: Nausea, Subcutaneous Abscess, Disseminated Cryptococcosis, Encephalitis, Pyrexia, Headache, Somnolence, Viith Nerve Paralysis, Cryptococcosis, Syncope, Cryptococcal Fungaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone



Possible Prednisone side effects in 61 year old male

Reported by a consumer/non-health professional from Germany on 2012-05-07

Patient: 61 year old male

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Belatacept
    Indication: Renal Transplant
    Start date: 2007-01-26

Mycophenolate Mofetil (Cellcept)
    Start date: 2008-08-13

Prednisone
    Start date: 2007-08-30

Other drugs received by patient: Allopurinol



Possible Prednisone side effects in 63 year old male

Reported by a individual with unspecified qualification from Germany on 2012-05-04

Patient: 63 year old male

Reactions: Dehydration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Prednisone side effects in 32 year old male

Reported by a health professional (non-physician/pharmacist) from Tunisia on 2012-05-02

Patient: 32 year old male

Reactions: Multi-Organ Failure, Impaired Healing, Bacterial Sepsis, Aspergillosis, Febrile Neutropenia, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Lymphoma

Cyclophosphamide
    Indication: Lymphoma

Doxorubicin Hydrochloride
    Indication: Lymphoma

Etoposide
    Indication: Lymphoma

Prednisone
    Indication: Lymphoma

Other drugs received by patient: Ceftazidime; Amikacin



Possible Prednisone side effects in 8 year old female

Reported by a physician from United States on 2012-05-02

Patient: 8 year old female, weighing 41.9 kg (92.2 pounds)

Reactions: Atelectasis, Blood Urea Increased, Blood Potassium Increased, Pyrexia, Disease Progression, Procedural Haemorrhage, Heart Rate Increased, Bone Marrow Failure, Pleural Effusion, Aspergillosis, Enterococcus Test Positive, Pulmonary Oedema, Lung Infiltration, Tracheitis, Blood Pressure Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 440 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-06
    End date: 2012-01-10

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2012-01-30

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2011-12-02

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-06
    End date: 2012-01-10

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2012-01-06

Pegaspargase
    Dosage: 2500 unk, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2012-01-04

Prednisone
    Dosage: 20 mg/m2, unk
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2012-01-13

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-02
    End date: 2011-12-23



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017